tirzepatide

semaglutide

retatrutide

HOT SELL

SLU-PP-332 is a compound which is a potent but non-selective estrogen-related receptor (ERR) agonist, acting most strongly at ERRα with an EC50 of 98 nM. It was found to counteract metabolic syndrome in mice, suggesting a possible role for compounds from this class as medications for the treatment of obesity

Tesofensine, GHKCU, SHAP-8

Tesofensine (formerly known as NS2330) is a potent triple monoamine reuptake inhibitor. It was originally developed by the Danish pharmaceutical company NeuroSearch for the treatment of Alzheimer’s and Parkinson’s disease.

Although its clinical trials for neurological conditions were discontinued, a significant and unexpected side effect was observed: substantial weight loss in the participants. This led to its redevelopment as a novel anti-obesity drug.

Tesofensine, GHKCU, SHAP-8

SNAP-8 (Acetyl Octapeptide-3) is a synthetic peptide specifically designed for topical use in anti-aging skincare. It is a longer, more stable, and reportedly more effective version of the well-known peptide Argireline (Acetyl Hexapeptide-8).

Its name is an acronym for “Synaptic Neurotransmission Blocking Peptide”, which describes its primary mechanism of action.

Stay turned for the new raws list

Xraw-Peps_admin@protonmail.com

FDA Disclaimer

FDA Disclaimer: The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease.

Xraw-Peps, is a chemical supplier. We are not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. Xraw-Peps is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic act. All products are sold for research, laboratory, or analytical purposes only, and are not for human consumption.


© Copyright 2024 – Xraw-Peps